Logo-npj

Review

1. Diabetic kidney disease: world wide difference of prevalence and risk factors
Osama Gheith*, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi
J Nephropharmacol. 2016;5(1): 49-56.
Article
PDF
XML
Cited By:
Original

2. Evaluating risk factors for catheter-related infections in hemodialysis patients
Sepideh Hajian* ORCID, Moosa Seifzade ORCID
J Nephropharmacol. 2022;11(2): e10489. doi: 10.34172/npj.2022.10489
Article
PDF
XML
Cited By:
0
Mini-Review

3. Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review
Shiva Toumaj ORCID, Shahrzad Alimohammadi ORCID, Maryam Ghasemi ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10605. doi: 10.34172/npj.2023.10605
Scopus ID: 85162004368    
Article
PDF
XML
Cited By:
0
0
Original

4. Determining the alteration of ghrelin and some biochemical parameters in end-stage kidney disease patients on hemodialysis
Khalid Shaalan Sahab ORCID, Mohammed Asaad Mahdi* ORCID, Ammar M. AL-Azzawi ORCID
J Nephropharmacol. 2025;14(1): e11677. doi: 10.34172/npj.2025.11677
Scopus ID: 85218224908    
Article
PDF
XML
Cited By:
0
0